The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orabona, C.
Right arrow Articles by Puccetti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orabona, C.
Right arrow Articles by Puccetti, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-TRYPTOPHAN
The Journal of Immunology, 2005, 174: 6582-6586.
Copyright © 2005 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Silencing Suppressor of Cytokine Signaling 3 Expression in Dendritic Cells Turns CD28-Ig from Immune Adjuvant to Suppressant1

Ciriana Orabona, Maria Laura Belladonna, Carmine Vacca, Roberta Bianchi, Francesca Fallarino, Claudia Volpi, Stefania Gizzi, Maria Cristina Fioretti, Ursula Grohmann and Paolo Puccetti2

Department of Experimental Medicine, University of Perugia, Perugia, Italy

CTLA-4-Ig and CD28-Ig are both agonist ligands of B7 coreceptor molecules on mouse dendritic cells (DCs), yet they bias the downstream response in opposite directions, and CTLA-4-Ig promotes tolerance, whereas CD28-Ig favors the onset of immunity. Although B7 engagement by either ligand leads to a mixed cytokine response, a dominant IL-6 production in response to CD28-Ig prevents the IFN-{gamma}-driven induction of immunosuppressive tryptophan catabolism mediated by IDO. In the present study, we show that silencing the expression of suppressor of cytokine signaling 3 (SOCS3) in DCs by RNA interference renders CD28-Ig capable of activating IDO, likely as a result of unrestrained IFN-{gamma} signaling and IFN-{gamma}-like actions of IL-6. Thus, in the absence of SOCS3, CD28-Ig becomes immunosuppressive and mimics the action of CTLA-4-Ig on tryptophan catabolism.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Geisel, F. Kahl, M. Muller, H. Wagner, C. J. Kirschning, I. B. Autenrieth, and J.-S. Frick
IL-6 and Maturation Govern TLR2 and TLR4 Induced TLR Agonist Tolerance and Cross-Tolerance in Dendritic Cells
J. Immunol., November 1, 2007; 179(9): 5811 - 5818.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. De Luca, C. Montagnoli, T. Zelante, P. Bonifazi, S. Bozza, S. Moretti, C. D'Angelo, C. Vacca, L. Boon, F. Bistoni, et al.
Functional yet Balanced Reactivity to Candida albicans Requires TRIF, MyD88, and IDO-Dependent Inhibition of Rorc
J. Immunol., November 1, 2007; 179(9): 5999 - 6008.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Thomas, A. C. Terentis, H. Cai, O. Takikawa, A. Levina, P. A. Lay, M. Freewan, and R. Stocker
Post-translational Regulation of Human Indoleamine 2,3-Dioxygenase Activity by Nitric Oxide
J. Biol. Chem., August 17, 2007; 282(33): 23778 - 23787.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
W. Komyod, M. Bohm, D. Metze, P. C. Heinrich, and I. Behrmann
Constitutive Suppressor of Cytokine Signaling 3 Expression Confers a Growth Advantage to a Human Melanoma Cell Line
Mol. Cancer Res., March 1, 2007; 5(3): 271 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
A. Jewett, C. Head, and N.A. Cacalano
Emerging Mechanisms of Immunosuppression in Oral Cancers.
J. Dent. Res., December 1, 2006; 85(12): 1061 - 1073.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. L. Belladonna, U. Grohmann, P. Guidetti, C. Volpi, R. Bianchi, M. C. Fioretti, R. Schwarcz, F. Fallarino, and P. Puccetti
Kynurenine Pathway Enzymes in Dendritic Cells Initiate Tolerogenesis in the Absence of Functional IDO
J. Immunol., July 1, 2006; 177(1): 130 - 137.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Orabona, P. Puccetti, C. Vacca, S. Bicciato, A. Luchini, F. Fallarino, R. Bianchi, E. Velardi, K. Perruccio, A. Velardi, et al.
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
Blood, April 1, 2006; 107(7): 2846 - 2854.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Suzuki, F. Schirra, S. M. Richards, N. S. Treister, M. J. Lombardi, P. Rowley, R. V. Jensen, and D. A. Sullivan
Estrogen's and Progesterone's Impact on Gene Expression in the Mouse Lacrimal Gland
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 158 - 168.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-Y. Tseng, M. Liu, and M. L. Dustin
CD80 Cytoplasmic Domain Controls Localization of CD28, CTLA-4, and Protein Kinase C{theta} in the Immunological Synapse
J. Immunol., December 15, 2005; 175(12): 7829 - 7836.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
F. Fallarino, C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, C. Asselin-Paturel, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells
Int. Immunol., November 1, 2005; 17(11): 1429 - 1438.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.